US Patent Issued to Novartis on Sept. 29 for "Compositions and methods for selective protein degradation" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,272, issued on Sept. 29, was assigned to Novartis AG (Basel, Switzerland).

"Compositions and methods for selective protein degradation" was invented by Seth Carbonneau (Roxbury, Mass.), Marc Horst Peter Hild (Wellesley, Mass.), Andrei Golosov (Cambridge, Mass.) and Nicole Renaud (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions including a fusion polypeptide and methods for making a fusion polypeptide that includes a degradation polypeptide and a heterologous polypeptide of interest."

The patent was filed on April 23, 2020, under Application No. 17/605,859.

*For further information, including im...